Web Analytics
Bangla
Loading date...
RECENT THREADS SOCIAL PAGE LOGIN

Pharmaceutical companies in Bangladesh are aggressively offering doctors cash, electronics, and foreign trips in exchange for prescribing their drugs, including substandard or unnecessary ones. This unethical practice is inflating healthcare costs and endangering public health. Experts and regulators warn that many doctors are prioritizing incentives over patients’ wellbeing. Oversight is weak, allowing companies to exploit the system. Reforms are being planned, but enforcement remains limited. Foreign drug companies are exiting the market, unable to compete with these unethical tactics.

Card image

News Source

Jugantor 29 Jul 25

Patients Suffering Due to Pharmaceutical Company Incentives

Pharmaceutical companies are competing among themselves by offering lucrative incentives to doctors. These incentives include their own manufactured medicines, various electronics, foreign trips, household goods, and even cash. As a result, many doctors are prescribing specific brands—sometimes even substandard or unnecessary medications—just to receive these benefits. This is not only draining patients’ pockets but also putting public health at serious risk. Concerned stakeholders are demanding urgent measures to stop this disorder in the healthcare sector.


The ‘1 Nojor’ media platform is now live in beta, inviting users to explore and provide feedback as we continue to refine the experience.